What do patients think about personalized medicine? Giovanna Marsico (former director of the Cancer Contribution association), Catherine Cerisey (former patient, blogger, vice president of the Cancer Contribution) and Chantal Ardiot (representative of the health users, member of the CPP IdF2) discuss it in this video.
Acute Myeloid Leukemia: identification of a new targeted therapy approach
April 14, 2022
Acute myeloid leukemia (AML) is a hematologic malignancy that develops from hematopoietic stem
